Saturday, September 7, 2024
wellness India Expo
Home Tags GIP

Tag: GIP

Eli Lilly’s Tirzepatide approved by NMPA in China, boosting market position

Tirzepatide’s debut as the first dual GIP and GLP-1 receptor agonist for obesity in China strengthens Eli Lilly’s presence